BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Feng J, Li J, Wu L, Yu Q, Ji J, Wu J, Dai W, Guo C. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J Exp Clin Cancer Res 2020;39:126. [PMID: 32631382 DOI: 10.1186/s13046-020-01629-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 91] [Article Influence: 11.5] [Reference Citation Analysis]
Number Citing Articles
1 Dai W, Duan Y, Yuan W, Wang S. circTUBGCP5 promotes liver cancer progression and glycolysis by up-regulating the expression of ACSL4. Appl Biol Chem 2022;65. [DOI: 10.1186/s13765-022-00723-9] [Reference Citation Analysis]
2 Cai J, Chen X, Liu X, Li Z, Shi A, Tang X, Xia P, Zhang J, Yu P. AMPK: The key to ischemia-reperfusion injury. J Cell Physiol 2022. [PMID: 36134582 DOI: 10.1002/jcp.30875] [Reference Citation Analysis]
3 Dai Y, Chen H, Pan Y, Lv L, Wang W, Chen X, Zhou X. Characterization of chromatin regulators identified prognosis and heterogeneity in hepatocellular carcinoma. Front Oncol 2022;12:1002781. [DOI: 10.3389/fonc.2022.1002781] [Reference Citation Analysis]
4 Bao C, Zhu S, Song K, He C. HK2: a potential regulator of osteoarthritis via glycolytic and non-glycolytic pathways. Cell Commun Signal 2022;20:132. [PMID: 36042519 DOI: 10.1186/s12964-022-00943-y] [Reference Citation Analysis]
5 Zhou F, Ma J, Zhu Y, Wang T, Yang Y, Sun Y, Chen Y, Song H, Huo X, Zhang J. The role and potential mechanism of O-Glycosylation in gastrointestinal tumors. Pharmacol Res 2022;:106420. [PMID: 36049664 DOI: 10.1016/j.phrs.2022.106420] [Reference Citation Analysis]
6 Gao Z, Chen J, Zhou Y, Deng P, Sun L, Qi J, Zhang P, Zheng M. A Novel Metabolism-Related Gene Signature for Predicting the Prognosis of HBV-Infected Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/2391265] [Reference Citation Analysis]
7 Fan N, Fu H, Feng X, Chen Y, Wang J, Wu Y, Bian Y, Li Y. Long non-coding RNAs play an important regulatory role in tumorigenesis and tumor progression through aerobic glycolysis. Front Mol Biosci 2022;9:941653. [DOI: 10.3389/fmolb.2022.941653] [Reference Citation Analysis]
8 Wang X, Zhang P, Deng K, Andreucci E. MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma. Analytical Cellular Pathology 2022;2022:1-17. [DOI: 10.1155/2022/1435173] [Reference Citation Analysis]
9 Guo C, Tang Y, Yang Z, Li G, Zhang Y. Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates. Front Immunol 2022;13:958161. [DOI: 10.3389/fimmu.2022.958161] [Reference Citation Analysis]
10 Liu C, Huang R, Yu H, Gong Y, Wu P, Feng Q, Li X. Fuzheng Xiaozheng prescription exerts anti-hepatocellular carcinoma effects by improving lipid and glucose metabolisms via regulating circRNA-miRNA-mRNA networks. Phytomedicine 2022;103:154226. [DOI: 10.1016/j.phymed.2022.154226] [Reference Citation Analysis]
11 Zhang T, Zhang Y, Yang Z, Jiang Y, Sun L, Huang D, Tian M, Shen Y, Deng J, Hou J, Ma Y. Echinococcus multilocularis protoscoleces enhance glycolysis to promote M2 Macrophages through PI3K/Akt/mTOR Signaling Pathway. Pathog Glob Health 2022;:1-8. [PMID: 35876088 DOI: 10.1080/20477724.2022.2104055] [Reference Citation Analysis]
12 Ren YX, Li XB, Liu W, Yang XG, Liu X, Luo Y. The Mechanism of Rac1 in Regulating HCC Cell Glycolysis Which Provides Underlying Therapeutic Target for HCC Therapy. J Oncol 2022;2022:7319641. [PMID: 35847360 DOI: 10.1155/2022/7319641] [Reference Citation Analysis]
13 Zheng J, Liu J, Zhu T, Liu C, Gao Y, Dai W, Zhuo W, Mao X, He B, Liu Z. Effects of Glycolysis-Related Genes on Prognosis and the Tumor Microenvironment of Hepatocellular Carcinoma. Front Pharmacol 2022;13:895608. [DOI: 10.3389/fphar.2022.895608] [Reference Citation Analysis]
14 Li D, Xie Y, Sun J, Zhang L, Jiang W, Yang D. LncRNA ZNF674-AS1 Hinders Proliferation and Invasion of Hepatic Carcinoma Cells through the Glycolysis Pathway. Journal of Oncology 2022;2022:1-9. [DOI: 10.1155/2022/8063382] [Reference Citation Analysis]
15 Chen Z, Hao W, Tang J, Gao W, Xu H. CSTF2 Promotes Hepatocarcinogenesis and Hepatocellular Carcinoma Progression via Aerobic Glycolysis. Front Oncol 2022;12:897804. [DOI: 10.3389/fonc.2022.897804] [Reference Citation Analysis]
16 Mooli RGR, Ramakrishnan SK. Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease. Front Physiol 2022;13:946474. [DOI: 10.3389/fphys.2022.946474] [Reference Citation Analysis]
17 Zhao J, Guo J, Wang Y, Ma Q, Shi Y, Cheng F, Lu Q, Fu W, Ouyang G, Zhang J, Xu Q, Hu X. Research Progress of DUB Enzyme in Hepatocellular Carcinoma. Front Oncol 2022;12:920287. [DOI: 10.3389/fonc.2022.920287] [Reference Citation Analysis]
18 Gao X, Jia X, Xu M, Xiang J, Lei J, Li Y, Lu Y, Zuo S. Regulation of Gamma-Aminobutyric Acid Transaminase Expression and Its Clinical Significance in Hepatocellular Carcinoma. Front Oncol 2022;12:879810. [DOI: 10.3389/fonc.2022.879810] [Reference Citation Analysis]
19 Liu T, Tang J, Li X, Lin Y, Yang Y, Ma K, Hui Z, Ma H, Qin Y, Lei H, Yang Y. The Key Network of mRNAs and miRNAs Regulated by HIF1A in Hypoxic Hepatocellular Carcinoma Cells. Front Genet 2022;13:857507. [DOI: 10.3389/fgene.2022.857507] [Reference Citation Analysis]
20 Li Y, Shimizu S, Mizumoto M, Iizumi T, Numajiri H, Makishima H, Li G, Sakurai H. Proton Beam Therapy for Multifocal Hepatocellular Carcinoma (HCC) Showing Complete Response in Pathological Anatomy After Liver Transplantation. Cureus. [DOI: 10.7759/cureus.25744] [Reference Citation Analysis]
21 Chen Q, Bao L, Huang Y, Lv L, Zhang G, Chen Y. Clinical significance and immunogenomic landscape analysis of glycolysis-associated prognostic model to guide clinical therapy in hepatocellular carcinoma. J Gastrointest Oncol 2022;13:1351-66. [PMID: 35837198 DOI: 10.21037/jgo-22-503] [Reference Citation Analysis]
22 Mishra AK, Singh SK, Dayanandan S, Banerjee S, Chakraborty S, Gopal AB, Samal S, Poirah I, Chakraborty D, Bhattacharyya A. Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster. Cytokine 2022;156:155917. [PMID: 35660715 DOI: 10.1016/j.cyto.2022.155917] [Reference Citation Analysis]
23 Wu Y, Xu X, Liu M, Qin X, Wu Q, Ding H, Zhao Q. DZW-310, a novel phosphoinositide 3-kinase inhibitor, attenuates the angiogenesis and growth of hepatocellular carcinoma cells via PI3K/AKT/mTOR axis. Biochem Pharmacol 2022;:115093. [PMID: 35580648 DOI: 10.1016/j.bcp.2022.115093] [Reference Citation Analysis]
24 Wang L, Xie Y, Wang J, Zhang Y, Liu S, Zhan Y, Zhao Y, Li J, Li P, Wang C. Characterization of a Novel LUCAT1/miR-4316/VEGF-A Axis in Metastasis and Glycolysis of Lung Adenocarcinoma. Front Cell Dev Biol 2022;10:833579. [DOI: 10.3389/fcell.2022.833579] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Li Z, Lei G, Meng X, Yang Z. Identification of a new five-gene risk score for risk stratification and prognosis prediction in HCC. Nucleosides Nucleotides Nucleic Acids 2022;:1-19. [PMID: 35532340 DOI: 10.1080/15257770.2022.2071445] [Reference Citation Analysis]
26 Zhou L, Fu Z, Wang S, Jia J, Cheng Y, Zheng Y, Zhang N, Lu W, Yao Z. ACYP1 Is a Pancancer Prognostic Indicator and Affects the Immune Microenvironment in LIHC. Front Oncol 2022;12:875097. [DOI: 10.3389/fonc.2022.875097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zhu QW, Yu Y, Zhang Y, Wang XH. VLCAD inhibits the proliferation and invasion of hepatocellular cancer cells through regulating PI3K/AKT axis. Clin Transl Oncol 2022;24:864-74. [PMID: 35001339 DOI: 10.1007/s12094-021-02733-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Wu Z, Wang H, Shi Z, Li Y, Cui Q. Propofol Prevents the Growth, Migration, Invasion, and Glycolysis of Colorectal Cancer Cells by Downregulating Lactate Dehydrogenase Both In Vitro and In Vivo. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/8317466] [Reference Citation Analysis]
29 Huang J, Zhuang C, Chen J, Chen X, Li X, Zhang T, Wang B, Feng Q, Zheng X, Gong M, Gong Q, Xiao K, Luo K, Li W. Targeted Drug/Gene/Photodynamic Therapy via a Stimuli-Responsive Dendritic-Polymer-Based Nanococktail for Treatment of EGFR-TKI-Resistant Non-Small-Cell Lung Cancer. Adv Mater 2022;:e2201516. [PMID: 35481881 DOI: 10.1002/adma.202201516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Yu Q, Dai W, Ji J, Wu L, Feng J, Li J, Zheng Y, Li Y, Cheng Z, Zhang J, Wu J, Xu X, Guo C. Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the c‐myc/hexokinase 2 pathway. J Cellular Molecular Medi. [DOI: 10.1111/jcmm.17322] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Bashir M, Yousuf I, Prakash Prasad C. Mixed Ni(II) and Co(II) complexes of nalidixic acid drug: Synthesis, characterization, DNA/BSA binding profile and in vitro cytotoxic evaluation against MDA-MB-231 and HepG2 cancer cell lines. Spectrochim Acta A Mol Biomol Spectrosc 2022;271:120910. [PMID: 35077983 DOI: 10.1016/j.saa.2022.120910] [Reference Citation Analysis]
32 Huang L, Liang A, Li T, Lei X, Chen X, Liao B, Tang J, Cao X, Chen G, Chen F, Wang Y, Hu L, He W, Li M. Mogroside V Improves Follicular Development and Ovulation in Young-Adult PCOS Rats Induced by Letrozole and High-Fat Diet Through Promoting Glycolysis. Front Endocrinol 2022;13:838204. [DOI: 10.3389/fendo.2022.838204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Chen Z, Du J, Yang C, Si G, Chen Y. circ-CFH promotes the development of HCC by regulating cell proliferation, apoptosis, migration, invasion, and glycolysis through the miR-377-3p/RNF38 axis. Open Life Sciences 2022;17:248-60. [DOI: 10.1515/biol-2022-0029] [Reference Citation Analysis]
34 Cai J, Chen Z, Zhang Y, Wang J, Zhang Z, Wu J, Mao J, Zuo X. CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma. Mol Ther Oncolytics 2022;24:755-71. [PMID: 35317519 DOI: 10.1016/j.omto.2022.02.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Allen CNS, Arjona SP, Santerre M, Sawaya BE. Hallmarks of Metabolic Reprogramming and Their Role in Viral Pathogenesis. Viruses 2022;14:602. [DOI: 10.3390/v14030602] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Speciale A, Muscarà C, Molonia MS, Cristani M, Cimino F, Saija A. Recent Advances in Glycyrrhetinic Acid-Functionalized Biomaterials for Liver Cancer-Targeting Therapy. Molecules 2022;27:1775. [PMID: 35335138 DOI: 10.3390/molecules27061775] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Park Y, Han Y, Kim D, Cho S, Kim W, Hwang H, Lee HW, Han DH, Kim KS, Yun M, Lee M. Impact of Exogenous Treatment with Histidine on Hepatocellular Carcinoma Cells. Cancers 2022;14:1205. [DOI: 10.3390/cancers14051205] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Liu M, Du Q, Mao G, Dai N, Zhang F. MYB proto-oncogene like 2 promotes hepatocellular carcinoma growth and glycolysis via binding to the Optic atrophy 3 promoter and activating its expression. Bioengineered 2022;13:5344-56. [PMID: 35176941 DOI: 10.1080/21655979.2021.2017630] [Reference Citation Analysis]
39 Yan X, Tian R, Sun J, Zhao Y, Liu B, Su J, Li M, Sun W, Xu X. Sorafenib-Induced Autophagy Promotes Glycolysis by Upregulating the p62/HDAC6/HSP90 Axis in Hepatocellular Carcinoma Cells. Front Pharmacol 2022;12:788667. [DOI: 10.3389/fphar.2021.788667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Kong J, Yu G, Si W, Li G, Chai J, Liu Y, Liu J. Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09209-9] [Reference Citation Analysis]
41 Zhu XL, Li Q, Shen J, Shan L, Zuo ED, Cheng X. Use of 6 m6A-relevant lncRNA genes as prognostic markers of primary liver hepatocellular carcinoma based on TCGA database. Transl Cancer Res 2021;10:5337-51. [PMID: 35116381 DOI: 10.21037/tcr-21-2440] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
42 Lei Y, Han P, Chen Y, Wang H, Wang S, Wang M, Liu J, Yan W, Tian D, Liu M. Protein arginine methyltransferase 3 promotes glycolysis and hepatocellular carcinoma growth by enhancing arginine methylation of lactate dehydrogenase A. Clin Transl Med 2022;12:e686. [PMID: 35090076 DOI: 10.1002/ctm2.686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
43 Cai Q, Zhu M, Duan J, Wang H, Chen J, Xiao Y, Wang Y, Wang J, Yu X, Yang H. Comprehensive Analysis of Immune-Related Prognosis of TK1 in Hepatocellular Carcinoma. Front Oncol 2022;11:786873. [DOI: 10.3389/fonc.2021.786873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Loh D, Reiter RJ. Melatonin: Regulation of Prion Protein Phase Separation in Cancer Multidrug Resistance. Molecules 2022;27:705. [PMID: 35163973 DOI: 10.3390/molecules27030705] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
45 Sruthi CR, Raghu KG. Methylglyoxal induces ambience for cancer promotion in HepG2 cells via Warburg effect and promotes glycation. J Cell Biochem 2022. [PMID: 35043457 DOI: 10.1002/jcb.30215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
46 Zhang H, Yin X, Zhang X, Zhou M, Xu W, Wei Z, Song C, Han S, Han W. HSP90AB1 Promotes the Proliferation, Migration, and Glycolysis of Head and Neck Squamous Cell Carcinoma. Technol Cancer Res Treat 2022;21:15330338221118202. [PMID: 35929142 DOI: 10.1177/15330338221118202] [Reference Citation Analysis]
47 Zhou S, Guo Z, Lv X, Zhang X. CircGOT1 promotes cell proliferation, mobility, and glycolysis-mediated cisplatin resistance via inhibiting its host gene GOT1 in esophageal squamous cell cancer. Cell Cycle 2021;:1-14. [PMID: 34919012 DOI: 10.1080/15384101.2021.2015671] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Cao X, Meng X, Fu P, Wu L, Yang Z, Chen H. circATP2A2 promotes osteosarcoma progression by upregulating MYH9. Open Med (Wars) 2021;16:1749-61. [PMID: 34901459 DOI: 10.1515/med-2021-0370] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Icard P, Simula L, Wu Z, Berzan D, Sogni P, Dohan A, Dautry R, Coquerel A, Lincet H, Loi M, Fuks D. Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma? Drug Resist Updat 2021;:100790. [PMID: 34924279 DOI: 10.1016/j.drup.2021.100790] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Zhang Z, Zhang HJ. Glycometabolic rearrangements-aerobic glycolysis in pancreatic ductal adenocarcinoma (PDAC): roles, regulatory networks, and therapeutic potential. Expert Opin Ther Targets 2021;:1-17. [PMID: 34874212 DOI: 10.1080/14728222.2021.2015321] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Ren H, Li W, Liu X, Li S, Guo H, Wang W, Zhao N. Identification and Validation of an 6-Metabolism-Related Gene Signature and Its Correlation With Immune Checkpoint in Hepatocellular Carcinoma. Front Oncol 2021;11:783934. [PMID: 34869039 DOI: 10.3389/fonc.2021.783934] [Reference Citation Analysis]
52 Wu Q, Wang SP, Sun XX, Tao YF, Yuan XQ, Chen QM, Dai L, Li CL, Zhang JY, Yang AL. HuaChanSu suppresses tumor growth and interferes with glucose metabolism in hepatocellular carcinoma cells by restraining Hexokinase-2. Int J Biochem Cell Biol 2022;142:106123. [PMID: 34826616 DOI: 10.1016/j.biocel.2021.106123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Li C, Chen J, Li Y, Wu B, Ye Z, Tian X, Wei Y, Hao Z, Pan Y, Zhou H, Yang K, Fu Z, Xu J, Lu Y. 6-Phosphogluconolactonase Promotes Hepatocellular Carcinogenesis by Activating Pentose Phosphate Pathway. Front Cell Dev Biol 2021;9:753196. [PMID: 34765603 DOI: 10.3389/fcell.2021.753196] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
54 Zheng X, Gou Y, Jiang Z, Yang A, Yang Z, Qin S. Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis via Regulating the JAK2/STAT3 Pathway in Hepatocellular Carcinoma. Front Oncol 2021;11:740557. [PMID: 34765550 DOI: 10.3389/fonc.2021.740557] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
55 Jiang X, Zhang W, Li L, Xie S. Integrated Transcriptomic Analysis Revealed Hub Genes and Pathways Involved in Sorafenib Resistance in Hepatocellular Carcinoma. Pathol Oncol Res 2021;27:1609985. [PMID: 34737677 DOI: 10.3389/pore.2021.1609985] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Wu L, Liu J, Li W. Prognostic significance of a 4-lncRNA glycolysis-related signature in oral squamous cell carcinoma. Journal of Dental Sciences 2021. [DOI: 10.1016/j.jds.2021.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Soni VK, Mehta A, Ratre YK, Chandra V, Shukla D, Kumar A, Vishvakarma NK. Counteracting Action of Curcumin on High Glucose-Induced Chemoresistance in Hepatic Carcinoma Cells. Front Oncol 2021;11:738961. [PMID: 34692517 DOI: 10.3389/fonc.2021.738961] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
58 Qian L, Li Y, Cao Y, Meng G, Peng J, Li H, Wang Y, Xu T, Zhang L, Sun B, Li B, Yu D. Pan-Cancer Analysis of Glycolytic and Ketone Bodies Metabolic Genes: Implications for Response to Ketogenic Dietary Therapy. Front Oncol 2021;11:689068. [PMID: 34692477 DOI: 10.3389/fonc.2021.689068] [Reference Citation Analysis]
59 Tayel F, Mahfouz ME, Salama AF, Mansour MA. Ethoxyquin Inhibits the Progression of Murine Ehrlich Ascites Carcinoma through the Inhibition of Autophagy and LDH. Biomedicines 2021;9:1526. [PMID: 34829755 DOI: 10.3390/biomedicines9111526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Li L, Ji Y, Zhang L, Cai H, Ji Z, Gu L, Yang S. Wogonin inhibits the growth of HT144 melanoma via regulating hedgehog signaling-mediated inflammation and glycolysis. Int Immunopharmacol 2021;101:108222. [PMID: 34688155 DOI: 10.1016/j.intimp.2021.108222] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
61 Zhao N, Zhang J, Zhao Q, Chen C, Wang H. Mechanisms of Long Non-Coding RNAs in Biological Characteristics and Aerobic Glycolysis of Glioma. Int J Mol Sci 2021;22:11197. [PMID: 34681857 DOI: 10.3390/ijms222011197] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
62 Liu R, Gou D, Xiang J, Pan X, Gao Q, Zhou P, Liu Y, Hu J, Wang K, Tang N. O-GlcNAc modified-TIP60/KAT5 is required for PCK1 deficiency-induced HCC metastasis. Oncogene 2021. [PMID: 34650217 DOI: 10.1038/s41388-021-02058-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
63 Lee AQ, Li Y, Gong Z. Inducible Liver Cancer Models in Transgenic Zebrafish to Investigate Cancer Biology. Cancers (Basel) 2021;13:5148. [PMID: 34680297 DOI: 10.3390/cancers13205148] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
64 Cho AR, Park WY, Lee HJ, Sim DY, Im E, Park JE, Ahn CH, Shim BS, Kim SH. Antitumor Effect of Morusin via G1 Arrest and Antiglycolysis by AMPK Activation in Hepatocellular Cancer. Int J Mol Sci 2021;22:10619. [PMID: 34638959 DOI: 10.3390/ijms221910619] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
65 Jia G, Wang Y, Lin C, Lai S, Dai H, Wang Z, Dai L, Su H, Song Y, Zhang N, Feng Y, Tang B. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2. J Exp Clin Cancer Res 2021;40:299. [PMID: 34551796 DOI: 10.1186/s13046-021-02090-7] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
66 Huang C, Shen Y, Shen M, Fan X, Men R, Ye T, Yang L. Glucose Metabolism Reprogramming of Regulatory T Cells in Concanavalin A-Induced Hepatitis. Front Pharmacol 2021;12:726128. [PMID: 34531750 DOI: 10.3389/fphar.2021.726128] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
67 Kim TS, Lee M, Park M, Kim SY, Shim MS, Lee CY, Choi DH, Cho Y. Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1. Int J Mol Sci 2021;22:10027. [PMID: 34576192 DOI: 10.3390/ijms221810027] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
68 Chen Z, Zou Y, Zhang Y, Chen Z, Wu F, Shi N, Jin H. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma. J Clin Lab Anal 2021;35:e24005. [PMID: 34523732 DOI: 10.1002/jcla.24005] [Reference Citation Analysis]
69 Mancuso A, Pourfathi M, Kiefer RM, Noji MC, Siddiqui S, Profka E, Weber CN, Pantel A, Kadlecek SJ, Rizi R, Gade TPF. Radial Flow Perfusion Enables Real-Time Profiling of Cellular Metabolism at Low Oxygen Levels with Hyperpolarized 13C NMR Spectroscopy. Metabolites 2021;11:576. [PMID: 34564392 DOI: 10.3390/metabo11090576] [Reference Citation Analysis]
70 Wu J, Qiao S, Xiang Y, Cui M, Yao X, Lin R, Zhang X. Endoplasmic reticulum stress: Multiple regulatory roles in hepatocellular carcinoma. Biomed Pharmacother 2021;142:112005. [PMID: 34426262 DOI: 10.1016/j.biopha.2021.112005] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
71 Sun T, Liu Z, Bi F, Yang Q. Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2. Mol Oncol 2021. [PMID: 34382324 DOI: 10.1002/1878-0261.13076] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
72 Liu C, Zhang W, Wang J, Si T, Xing W. Tumor-associated macrophage-derived transforming growth factor-β promotes colorectal cancer progression through HIF1-TRIB3 signaling. Cancer Sci 2021. [PMID: 34375482 DOI: 10.1111/cas.15101] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
73 Zheng Y, Li Y, Feng J, Li J, Ji J, Wu L, Yu Q, Dai W, Wu J, Zhou Y, Guo C. Cellular based immunotherapy for primary liver cancer. J Exp Clin Cancer Res 2021;40:250. [PMID: 34372912 DOI: 10.1186/s13046-021-02030-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
74 Gong T, Wang X, Ma Q, Li J, Li M, Huang Y, Liang W, Su D, Guo R. Triformyl cholic acid and folic acid functionalized magnetic graphene oxide nanocomposites: Multiple-targeted dual-modal synergistic chemotherapy/photothermal therapy for liver cancer. J Inorg Biochem 2021;223:111558. [PMID: 34329998 DOI: 10.1016/j.jinorgbio.2021.111558] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
75 Sun X, Huang Q, Peng F, Wang J, Zhao W, Guo G. Expression and Clinical Significance of HKII and HIF-1α in Grade Groups of Prostate Cancer. Front Genet 2021;12:680928. [PMID: 34220956 DOI: 10.3389/fgene.2021.680928] [Reference Citation Analysis]
76 Samec M, Liskova A, Koklesova L, Zhai K, Varghese E, Samuel SM, Šudomová M, Lucansky V, Kassayova M, Pec M, Biringer K, Brockmueller A, Kajo K, Hassan STS, Shakibaei M, Golubnitschaja O, Büsselberg D, Kubatka P. Metabolic Anti-Cancer Effects of Melatonin: Clinically Relevant Prospects. Cancers (Basel) 2021;13:3018. [PMID: 34208645 DOI: 10.3390/cancers13123018] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
77 Pan Y, Hu GY, Jiang S, Xia SJ, Maher H, Lin ZJ, Mao QJ, Zhao J, Cai LX, Xu YH, Xu JJ, Cai XJ. Development of an Aerobic Glycolysis Index for Predicting the Sorafenib Sensitivity and Prognosis of Hepatocellular Carcinoma. Front Oncol 2021;11:637971. [PMID: 34094917 DOI: 10.3389/fonc.2021.637971] [Reference Citation Analysis]
78 Shen C, Ding L, Mo H, Liu R, Xu Q, Tu K. Long noncoding RNA FIRRE contributes to the proliferation and glycolysis of hepatocellular carcinoma cells by enhancing PFKFB4 expression. J Cancer 2021;12:4099-108. [PMID: 34093813 DOI: 10.7150/jca.58097] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
79 Yang M, Ma X, Wang Z, Zhang T, Hua Y, Cai Z. Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients. Aging (Albany NY) 2021;13:12896-918. [PMID: 33952718 DOI: 10.18632/aging.202958] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
80 Zhang XP, Chen Q, Liu Q, Wang Y, Wang F, Zhao ZM, Zhao GD, Lau WY, Gao YZ, Liu R. Development and validation of glycolysis-related prognostic score for prediction of prognosis and chemosensitivity of pancreatic ductal adenocarcinoma. J Cell Mol Med 2021;25:5615-27. [PMID: 33942483 DOI: 10.1111/jcmm.16573] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
81 Shu DY, Butcher ER, Saint-Geniez M. Suppression of PGC-1α Drives Metabolic Dysfunction in TGFβ2-Induced EMT of Retinal Pigment Epithelial Cells. Int J Mol Sci 2021;22:4701. [PMID: 33946753 DOI: 10.3390/ijms22094701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
82 Wang P, Xiao T, Li J, Wang D, Sun J, Cheng C, Ma H, Xue J, Li Y, Zhang A, Liu Q. miR-21 in EVs from pulmonary epithelial cells promotes myofibroblast differentiation via glycolysis in arsenic-induced pulmonary fibrosis. Environ Pollut 2021;286:117259. [PMID: 33965804 DOI: 10.1016/j.envpol.2021.117259] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
83 Chen H, Wu Q, Peng L, Cao T, Deng M, Liu Y, Huang J, Hu Y, Fu N, Zhou K, Yang M, Yang X, Tan S. Mechanism, Clinical Significance, and Treatment Strategy of Warburg Effect in Hepatocellular Carcinoma. Journal of Nanomaterials 2021;2021:1-10. [DOI: 10.1155/2021/5164100] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
84 Dong F, Li R, Wang J, Zhang Y, Yao J, Jiang SH, Hu X, Feng M, Bao Z. Hypoxia-dependent expression of MAP17 coordinates the Warburg effect to tumor growth in hepatocellular carcinoma. J Exp Clin Cancer Res 2021;40:121. [PMID: 33832535 DOI: 10.1186/s13046-021-01927-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
85 Duan Z, Luo Y. Targeting macrophages in cancer immunotherapy. Signal Transduct Target Ther 2021;6:127. [PMID: 33767177 DOI: 10.1038/s41392-021-00506-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 76] [Article Influence: 4.0] [Reference Citation Analysis]
86 Che K, Han W, Li D, Cui S, Zhang M, Yang X, Niu H. Correlations between glycolysis with clinical traits and immune function in bladder urothelial carcinoma. Biosci Rep 2021;41:BSR20203982. [PMID: 33558879 DOI: 10.1042/BSR20203982] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
87 Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, Yi P, Tang L, Pan Q, Rao S, Liang J, Tang Y, Su M, Luo X, Yang Y, Shi Y, Wang H, Zhou Y, Liao Q. The cancer metabolic reprogramming and immune response. Mol Cancer 2021;20:28. [PMID: 33546704 DOI: 10.1186/s12943-021-01316-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 52] [Article Influence: 9.0] [Reference Citation Analysis]
88 Li X, Li Y, Bai S, Zhang J, Liu Z, Yang J. NR2F1-AS1/miR-140/HK2 Axis Regulates Hypoxia-Induced Glycolysis and Migration in Hepatocellular Carcinoma. Cancer Manag Res 2021;13:427-37. [PMID: 33488124 DOI: 10.2147/CMAR.S266797] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
89 Zhuo C, Yi T, Pu J, Cen X, Zhou Y, Feng S, Wei C, Chen P, Wang W, Bao C, Wang J, Tang Q. Exosomal linc-FAM138B from cancer cells alleviates hepatocellular carcinoma progression via regulating miR-765. Aging (Albany NY) 2020;12:26236-47. [PMID: 33401249 DOI: 10.18632/aging.202430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
90 Zhang Y, Zhao L, Yang S, Cen Y, Zhu T, Wang L, Xia L, Liu Y, Zou J, Xu J, Li Y, Cheng X, Lu W, Wang X, Xie X. CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression. J Exp Clin Cancer Res 2020;39:281. [PMID: 33308298 DOI: 10.1186/s13046-020-01793-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
91 Yu Q, Wu L, Ji J, Feng J, Dai W, Li J, Wu J, Guo C. Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma. J Hepatocell Carcinoma 2020;7:271-88. [PMID: 33150145 DOI: 10.2147/JHC.S277870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]